Top Markets
Coin of the day
DocMorris AG DocMorris AG

DocMorris AG

DOCM
Rangering i aksjer #11450
DocMorris AG is a key player in the pharmaceutical sector, focusing on both... DocMorris AG is a key player in the pharmaceutical sector, focusing on both online pharmacy services and the wholesale supply of medical and pharmaceutical goods. The company provides a comprehensive selection of items, including prescription and over-the-counter medications, health and wellness products, beauty and personal care lines, dietary supplements, pain relief remedies, and emergency first aid supplies. Furthermore, it offers specialized medication management support. In addition to its significant digital footprint, DocMorris AG also operates traditional brick-and-mortar pharmacy locations. Its commercial activities extend across Switzerland and into various international territories, serving medical practitioners, other online pharmaceutical distributors, and individual consumers directly. Notable brands within its portfolio include Zur Rose, PromoFarma, TeleClinic, and DocMorris. Established in 1993 and based in Frauenfeld, Switzerland, the company adopted its current name, DocMorris AG, in May 2023, having previously been known as Zur Rose Group AG.
Aksjekurs
$14.31
Sist synkronisert: 2026-08-28
Markedsverdi
$699.41M
Endring (1 dag)
3.38%
Endring (1 år)
73.52%
Land
CH
Handel DocMorris AG (DOCM)

Kategori

Inntekter for DocMorris AG (DOCM)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til DocMorris AG er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for DocMorris AG fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$410.98B -
US
- -
US
$254.25B -
US
- -
US
$7.64B -
AU